Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment.

Reinhard Hiller1, Sylvia Laffer, Christian Harwanegg

  • 1VBC-GENOMICS, A-1030 Vienna, Austria.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|January 16, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ozone alters the allergenicity of Ambrosia artemisiifolia pollen in a dose-dependent manner.

Environment international·2026
Same author

Multi-country IgE reactivity determination of isoforms of the <i>Blomia tropicalis</i> mite allergen Blo t 2 revealed a potential biomarker of asthma severity.

Frontiers in immunology·2026
Same author

Maternal-infant immune signatures in infants at risk for SARS-CoV-2-associated neurodevelopmental disorders.

Communications biology·2026
Same author

Molecular allergen inhibition assay for allergen extract identity, purity, and potency assessment.

The Journal of allergy and clinical immunology·2026
Same author

Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization.

Nature microbiology·2026
Same author

Engineering Chimeric Hypoallergens for Safer and More Effective House Dust Mite Allergy Vaccines.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2025

A new microarray allergy test identifies specific disease-eliciting molecules by measuring immunoglobulin E (IgE) reactivity. This advancement offers precise allergy diagnosis, potentially transforming patient care and treatment strategies.

Area of Science:

  • Immunology
  • Allergy Diagnostics
  • Biotechnology

Background:

  • Type I allergy, an immunoglobulin E (IgE)-mediated hypersensitivity, affects over 25% of the population.
  • Current allergy diagnostics rely on allergen extracts, identifying sources but not specific disease-eliciting molecules.
  • Existing methods lack precision in pinpointing individual allergenic components responsible for allergic reactions.

Purpose of the Study:

  • To develop a miniaturized allergy test utilizing microarray technology.
  • To enable precise identification of disease-eliciting allergenic molecules.
  • To offer a comprehensive tool for monitoring patients' IgE reactivity profiles.

Main Methods:

  • Application of microarray technology to create a test with 94 purified allergen molecules.

Related Experiment Videos

  • Measurement of IgE reactivity profiles using minute serum samples.
  • Development of a high-throughput diagnostic tool for allergy assessment.

    • Main Results:

    • The allergen microarray allows for the determination of IgE reactivity to numerous allergens in a single measurement.
    • The test accurately identifies specific allergenic molecules, moving beyond allergen sources.
    • Demonstrated potential for monitoring allergic patients' immune responses.

    Conclusions:

    • The allergen microarray represents a significant advancement in allergy diagnostics.
    • This technology may revolutionize allergy diagnosis, prevention, and therapy.
    • Microarrayed antigens show promise for diagnosing autoimmune and infectious diseases as well.